Straits Times Index
3,322.08 -8.69 (-0.26%) S&P 500
5,354.03 +7.04 (+0.13%) Dow
38,845.58 +46.59 (+0.12%) Nasdaq
17,153.79 +20.66 (+0.12%) Bitcoin USD
69,914.57 +164.70 (+0.24%) CMC Crypto 200
1,449.44 +2.77 (+0.19%)
OGN Jul 2024 7.500 call
| Previous close | 13.00 |
| Open | 13.00 |
| Bid | 11.70 |
| Ask | 15.40 |
| Strike | 7.50 |
| Expiry date | 2024-07-19 |
| Day's range | 13.00 - 13.00 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksOrganon (OGN) Just Overtook the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Business WireEuropean Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
SHANGHAI, China & JERSEY CITY, N.J., May 24, 2024--European Medicines Agency validates Organon and Henlius marketing authorization filings for Prolia and Xgeva (denosumab) biosimilar candidate HLX14.
Business WireOrganon Announces Pricing of $1.0 Billion Senior Notes Offering
JERSEY CITY, N.J., May 08, 2024--Organon (NYSE: OGN) ("Organon"), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the "Co-Issuer" and, together with Organon, the "Companies"), have priced an offering of $500 million of 6.750% senior secured notes due 2034 (the "Secured Notes") and $500 million of 7.875% senior unsecured notes due 2034 (the "Unsecured
